Found: 25
Select item for more details and to access through your institution.
Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomized, double‐blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD‐JPN).
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3167, doi. 10.1111/dom.15644
- By:
- Publication type:
- Article
Glucose‐dependent insulinotropic polypeptide counteracts diet‐induced obesity along with reduced feeding, elevated plasma leptin and activation of leptin‐responsive and proopiomelanocortin neurons in the arcuate nucleus.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1534, doi. 10.1111/dom.15001
- By:
- Publication type:
- Article
Change in pharmacodynamic variables following once‐weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J‐mono substudy).
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 398, doi. 10.1111/dom.14882
- By:
- Publication type:
- Article
The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 12, p. 1279, doi. 10.1111/dom.12758
- By:
- Publication type:
- Article
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 3, p. 649, doi. 10.1007/s13300-024-01534-5
- By:
- Publication type:
- Article
Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 2173, doi. 10.1007/s13300-023-01485-3
- By:
- Publication type:
- Article
Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 3, p. 735, doi. 10.1007/s13300-020-00765-6
- By:
- Publication type:
- Article
Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 1, p. 133, doi. 10.1007/s13300-019-00726-8
- By:
- Publication type:
- Article
Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 3, p. 1019, doi. 10.1007/s13300-019-0605-7
- By:
- Publication type:
- Article
CAST: a novel protein of the cytomatrix at the active zone of synapses that forms a ternary complex with RIM1 and Munc13-1.
- Published in:
- Journal of Cell Biology, 2002, v. 158, n. 3, p. 577, doi. 10.1083/jcb.200202083
- By:
- Publication type:
- Article
A novel rabconnectin-3-binding protein that directly binds a GDP/GTP exchange protein for Rab3A small G protein implicated in Ca<sup>2+</sup> -dependent exocytosis of neurotransmitter.
- Published in:
- Genes to Cells, 2003, v. 8, n. 6, p. 537, doi. 10.1046/j.1365-2443.2003.00655.x
- By:
- Publication type:
- Article
Identification of activity-regulated proteins in the postsynaptic density fraction.
- Published in:
- Genes to Cells, 2002, v. 7, n. 2, p. 187, doi. 10.1046/j.1356-9597.2001.00505.x
- By:
- Publication type:
- Article
Nectin-dependent localization of ZO-1 at puncta adhaerentia junctions between the mossy fiber terminals and the dendrites of the pyramidal cells in the CA3 area of adult mouse hippocampus.
- Published in:
- Journal of Comparative Neurology, 2003, v. 460, n. 4, p. 514, doi. 10.1002/cne.10653
- By:
- Publication type:
- Article
Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70).
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 1, p. 75, doi. 10.1111/jdi.13922
- By:
- Publication type:
- Article
Characterization of Pd 60 Cu 40 Composite Membrane Prepared by a Reverse Build-Up Method for Hydrogen Purification.
- Published in:
- Energies (19961073), 2021, v. 14, n. 24, p. 8262, doi. 10.3390/en14248262
- By:
- Publication type:
- Article
Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin-changing study intending to gain patients' insights into insulin treatment with patient-reported health outcomes in actual clinical treatments ( INSIGHTs) study
- Published in:
- Journal of Diabetes Investigation, 2013, v. 4, n. 6, p. 560, doi. 10.1111/jdi.12086
- By:
- Publication type:
- Article
Ethnic difference in patients with type 2 diabetes mellitus in inter-East Asian populations: A systematic review and meta-analysis focusing on gene polymorphism.
- Published in:
- Journal of Diabetes, 2009, v. 1, n. 4, p. 255, doi. 10.1111/j.1753-0407.2009.00040.x
- By:
- Publication type:
- Article
Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diabetes.
- Published in:
- Endocrine Journal, 2017, v. 64, n. 12, p. 1165, doi. 10.1507/endocrj.ej17-0189
- By:
- Publication type:
- Article
Efficacy and safety analyses across 4 subgroups combining low and high age and body mass index groups in Japanese phase 3 studies of dulaglutide 0.75 mg after 26 weeks of treatment.
- Published in:
- Endocrine Journal, 2017, v. 64, n. 4, p. 449, doi. 10.1507/endocrj.ej16-0428
- By:
- Publication type:
- Article
Subgroup analysis of phase 3 studies of dulaglutide in Japanese patients with type 2 diabetes.
- Published in:
- Endocrine Journal, 2016, v. 63, n. 3, p. 263, doi. 10.1507/endocrj.ej15-0518
- By:
- Publication type:
- Article
A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial.
- Published in:
- Endocrine Journal, 2015, v. 62, n. 12, p. 1101, doi. 10.1507/endocrj.ej15-0401
- By:
- Publication type:
- Article
Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study.
- Published in:
- Endocrine Journal, 2014, v. 61, n. 10, p. 949, doi. 10.1507/endocrj.ej14-0147
- By:
- Publication type:
- Article
Efficacy and safety of stepwise introduction of insulin lispro mix 50 in Japanese patients with type 2 diabetes inadequately controlled by oral therapy.
- Published in:
- Endocrine Journal, 2013, v. 60, n. 6, p. 763, doi. 10.1507/endocrj.ej12-0411
- By:
- Publication type:
- Article
Optimization of in-gel protein digestion system in combination with thin-gel separation and negative staining in 96-well plate format.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2003, v. 17, n. 10, p. 1071, doi. 10.1002/rcm.1024
- By:
- Publication type:
- Article